All podcasts

Immune Response to COVID19 and its Vaccines

The COVID19 vaccines have the potential to squelch a dangerous pandemic. However, the public has many questions about their safety and efficacy that could limit their broad administration. Some of the questions concern the immune system, how it is affected by the vaccine, why two doses are necessary, and if the response is durable. Today’s podcast interviews Dr. Asha Brunings about the immunology of the COVID vaccine and the disease itself.

Dec 26, 2020 by Dr. Kevin Folta in Talking Biotech

Apple podcasts link Google podcasts link Spotify podcasts link

The COVID19 vaccines have the potential to squelch a dangerous pandemic. However, the public has many questions about their safety and efficacy that could limit their broad administration. Some of the questions concern the immune system, how it is affected by the vaccine, why two doses are necessary, and if the response is durable. Today’s podcast interviews Dr. Asha Brunings about the immunology of the COVID vaccine and the disease itself. # COLABRA Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/ # TALKING BIOTECH Twitter: https://twitter.com/talkingbiotech Website: https://www.colabra.app/podcasts/talking-biotech/ Instagram: https://www.instagram.com/colabrahq The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

Colabra

Get your whole lab on the same page today.

Learn more